$IQV

STAUB W RICHARD sold $1.3M of IQV

STAUB W RICHARD (See Remarks) sold 5,500 shares of IQVIA HOLDINGS INC. (IQV) at $232.68 ($1.28M total) on 2026-08-03.

Original reporting
SEC EDGAR · STAUB W RICHARD
Published Aug 4, 2026, 9:00 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 4, 2026, 9:17 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefInsider activity
Primary signal
$IQV
Neutral
medium confidence
Mentioned
$IQV
Relevance
6/10
alphai data visualization · based on SEC EDGAR
Decision brief

The 30-second read

$IQVNeutralLow
01

Why it matters

The only new fact is the reported open-market sale size, price, and post-transaction holdings; it does not include any company-specific operational or financial update.

02

Market read

Traders may note the insider sale for sentiment, but there is no fundamental catalyst in the filing.

03

What to watch

Insider sales can be driven by diversification, taxes, or pre-existing personal liquidity needs, and the filing does not indicate any change in IQVIA’s outlook.

Relevance 6/10Novelty 3/10Timing: filed 2026-08-04 after-hours; sale executed 2026-08-03

Background

The article is an SEC Form 4 insider transaction disclosure for IQVIA Holdings Inc.

Company-level read

Ticker impact

$IQVNeutralMedium confidence
Context

IQVIA Form 4 shows officer Richard Staub sold 5,500 shares at $232.68 on 2026-08-03 for about $1.28M.

Expected impact

Likely minimal near-term impact; any effect would be sentiment-only and typically fades.

Evidence & confidence

The filing is a primary-source Form 4, but it provides no earnings, guidance, deal, or regulatory catalyst. Insider sales are common and often not predictive without additional context.

Market effects

No clear sector read-through from a single insider sale at IQVIA.

None indicated.

None indicated.

Counterpoint

The absence of a 10b5-1 plan could be interpreted by some traders as less routine, potentially adding short-term skepticism.

Key entities

  • IQVIA Holdings Inc.

    Subject of the Form 4 insider transaction disclosure.

  • STAUB W RICHARD

    Officer who sold 5,500 shares of IQVIA on 2026-08-03.

Related articles

$IQVMed

5 Insightful Analyst Questions From IQVIA’s Q2 Earnings Call

IQVIA reported Q2 CY2026 results with revenue of $4.37B versus $4.30B estimates and adjusted EPS of $3.15 versus $3.03, with adjusted EBITDA of $994M. Management cited 6% organic growth and strong net new bookings. Full-year revenue guidance was lifted to $17.38B and adjusted EPS to $12.90. Analysts discussed bookings, outsourcing, AI, M&A, and margins.

Med

An IQVIA CEO Sold $26.1 Million as Bookings Hit a Record $3.15 Billion

IQVIA Holdings CEO sold about $26.1 million of stock appreciation rights with a Feb 2027 expiration, while retaining a large share position, according to the filing and article. The company reported Q2 revenue up 8.7% to $4.37B, adjusted EPS up 12.1% to $3.15, and record clinical bookings of $3.15B, raising full-year guidance to $17.475B.

MedAI 8/10

IQVIA Holdings Inc. Q2 2026 Earnings Call Summary

IQVIA reported Q2 2026 results and said organic revenue growth accelerated to 6% YoY, driven by improving market conditions and execution. Management raised full-year 2026 guidance, citing 100 bps higher organic growth and more M&A contribution. It expects flat adjusted EBITDA margins around 23.2% and noted Charles River asset acquisition added 50 bps to M&A growth.

$IQVMedAI 8/10

IQVIA Holdings (IQV) Soars on Revenue Growth Outlook, Strong Q2

IQVIA Holdings (NYSE:IQV) rose after reporting strong Q2 results and raising its full-year revenue growth outlook. Q2 revenue grew 8.7% to $4.37B, while attributable net income fell 3.7% to $256M. FY26 revenue guidance increased to $17.275B-$17.475B, with adjusted EBITDA $4.0B-$4.05B and buybacks of $2.819B authorized.